Results 121 to 130 of about 5,026 (202)

suPAR - a future risk marker [PDF]

open access: yesJournal of Internal Medicine, 2011
openaire   +1 more source

suPAR is the circulating factor in some but not all FSGS [PDF]

open access: yesNature Reviews Nephrology, 2014
Howard, Trachtman, Jochen, Reiser
openaire   +2 more sources

Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial. [PDF]

open access: yesCrit Care
Boyle AJ   +12 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor - What are the clinical potentials in psychiatry? [PDF]

open access: yesBrain Behav Immun Health
Huber FG   +4 more
europepmc   +1 more source

Biomarkers of systemic disease burden and outcomes after transcatheter tricuspid edge-to-edge repair. [PDF]

open access: yesBMC Cardiovasc Disord
Schlegl J   +9 more
europepmc   +1 more source

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank. [PDF]

open access: yesJ Am Heart Assoc
Sakr SM   +13 more
europepmc   +1 more source

Cord blood procalcitonin and soluble urokinase-type plasminogen activator receptor in predicting histological chorioamnionitis - A pilot study. [PDF]

open access: yesEur J Obstet Gynecol Reprod Biol X
Jalkanen K   +7 more
europepmc   +1 more source

Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. [PDF]

open access: yesJ Neurovirol
Gonzalez H   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy